-transparent.png){kind=logo}
The presence of a tissue plasminogen activator inhibitor in the epidermis was investigated. A partially purified tissue plasminogen activator from a Bowes melanoma cell line medium was used as a tissue plasminogen activator. Extracts of epidermis dissolved in a 10 mM phosphate buffer, pH 7.0, were found to contain a tissue plasminogen activator inhibitor. The same extracts also contained a urokinase inhibitor. It is not clear whether these inhibitors are the same. This study is the first to show the existence of a tissue plasminogen activator inhibitor in the epidermis.
Related Publications
K Hashimoto, and
I Katayama, and
K Nishioka
April 1989,
Nihon rinsho. Japanese journal of clinical medicine,
K Hashimoto, and
I Katayama, and
K Nishioka
January 1996,
Klinika oczna,
K Hashimoto, and
I Katayama, and
K Nishioka
January 2000,
Stroke,
K Hashimoto, and
I Katayama, and
K Nishioka
June 1996,
Stroke,
K Hashimoto, and
I Katayama, and
K Nishioka
March 1994,
Journal of clinical pathology,
K Hashimoto, and
I Katayama, and
K Nishioka
October 1987,
Thrombosis and haemostasis,
K Hashimoto, and
I Katayama, and
K Nishioka
April 1994,
Rinsho byori. The Japanese journal of clinical pathology,
K Hashimoto, and
I Katayama, and
K Nishioka
January 1988,
Arteriosclerosis (Dallas, Tex.),
K Hashimoto, and
I Katayama, and
K Nishioka
January 1996,
Haemostasis,
K Hashimoto, and
I Katayama, and
K Nishioka
January 1988,
Methods in enzymology,
